Chronic Graft Versus Host Disease (cGvHD) Latest Advances

Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.

Journal: JAMA dermatology

Published: August 12, 2026

Loss of MGAT3 Amplifies TGF-β Signaling to Promote Bronchiolitis Obliterans Progression.

Journal: Clinical laboratory

Published: August 08, 2026

Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application.

Journal: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

Published: July 19, 2026

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.

Journal: Transplantation and cellular therapy

Published: July 08, 2026

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Published: June 17, 2026

Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development.

Journal: Blood advances

Published: June 08, 2026

Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Journal: Transplant immunology

Published: May 18, 2026

Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

Journal: Blood advances

Published: April 08, 2026

TCR-αβ/CD 19 Depleted Graft Versus T Replete Graft With Post-Transplant Cyclophosphamide in Children Undergoing Haploidentical Donor Hematopoietic Stem Cell Transplantation for Inborn Errors of Immunity: A Comparative Analysis From India.

Journal: Pediatric transplantation

Published: April 08, 2026

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.

Journal: Cell transplantation

Published: April 04, 2026

Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host disease.

Journal: Frontiers in immunology

Published: March 30, 2026

Hyperpolarized 129Xe MRI in Pediatric Hematopoietic Stem Cell Transplant Recipients With and Without Bronchiolitis Obliterans Syndrome.

Journal: Pediatric pulmonology

Published: March 27, 2026

Chronic Graft Versus Host Disease (cGvHD) Latest Advances

Find the Latest Research About Chronic Graft Versus Host Disease (cGvHD)

Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.

Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.

Loss of MGAT3 Amplifies TGF-β Signaling to Promote Bronchiolitis Obliterans Progression.

Loss of MGAT3 Amplifies TGF-β Signaling to Promote Bronchiolitis Obliterans Progression.

Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application.

Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application.

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.

Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Versus Host Disease.

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Immune dynamics and predictive factors for chronic graft versus host disease following haploidentical hematopoietic stem cell transplantation in children

Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development.

Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development.

Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Belumosudil in patients with bronchiolitis obliterans syndrome phenotype of chronic lung allograft dysfunction: An exploratory single-center real-world retrospective study.

Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

TCR-αβ/CD 19 Depleted Graft Versus T Replete Graft With Post-Transplant Cyclophosphamide in Children Undergoing Haploidentical Donor Hematopoietic Stem Cell Transplantation for Inborn Errors of Immunity: A Comparative Analysis From India.

TCR-αβ/CD 19 Depleted Graft Versus T Replete Graft With Post-Transplant Cyclophosphamide in Children Undergoing Haploidentical Donor Hematopoietic Stem Cell Transplantation for Inborn Errors of Immunity: A Comparative Analysis From India.

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.

Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.

Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host disease.

Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host disease.

Hyperpolarized 129Xe MRI in Pediatric Hematopoietic Stem Cell Transplant Recipients With and Without Bronchiolitis Obliterans Syndrome.

Hyperpolarized 129Xe MRI in Pediatric Hematopoietic Stem Cell Transplant Recipients With and Without Bronchiolitis Obliterans Syndrome.